Thomas de Bretagne takes over as Managing Director

23/04/2020

Thomas de Bretagne is appointed Managing Director of Choice, a global player in swine genetics, represented by its subsidiaries in France, Poland, USA and Brazil.

He succeeds Pieter Antoon Seghers who, after 37 years in the field of swine genetics, has chosen to reduce his professional activity and pass on the torch.

With more than 15 years of experience in animal genetics, Thomas began his career at Pen Ar Lan as head of the research and development program between 2002 and 2010, and then joined bovine genetics and a broiler genetics company as Global Research and Development Director.

In August 2017, Thomas de Bretagne made a return to swine genetics as he joined Choice’s teams as Deputy Managing Director with the responsibility of the Management of Choice France and the supervision of the research and development team. A 2-year process was then initiated with Pieter Antoon Seghers to carry out this transition of management.

Pieter Antoon Seghers said: “I am very pleased to have had the opportunity to work with Thomas during this transition period. He has shown himself to be the right person to lead Choice towards the achievement of our ambitions. In addition to being passionate about swine genetics, Thomas proves to be an intelligent leader with the ability to unite his teams around a project.”

Thomas de Bretagne said: “I am very honored with this nomination and with the trust shareholders have in me to carry out this mission. For the past two years, I have been involved in the strategic decisions and principal management decisions of Choice, and I will do my utmost to lead Choice toward the goals we have set. I will continue to develop Choice by building on its strengths: a passionate and skilled team, fantastic partners and excellent products.”

Based in Bruz (35), Choice is the swine division of Groupe Grimaud. Groupe Grimaud is one of the leaders in multi-species animal genetics and biopharmaceuticals headquartered in Sèvremoine-Roussay (49), with a turnover of 300 million euros.

Additional information

For any information request, please contact us: info.fr@choice-genetics.com

Pin It on Pinterest

Share This